F-star Therapeutics - Stock Price History | FSTX

Historical daily share price chart and data for F-star Therapeutics since 2021 adjusted for splits. The latest closing stock price for F-star Therapeutics as of September 27, 2021 is 7.71.
  • The all-time high F-star Therapeutics stock closing price was 13.84 on March 25, 2021.
  • The F-star Therapeutics 52-week high stock price is 15.50, which is 101% above the current share price.
  • The F-star Therapeutics 52-week low stock price is 1.23, which is 84% below the current share price.
  • The average F-star Therapeutics stock price for the last 52 weeks is 7.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
F-star Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.4156 1.2000 10.3900 1.2000 9.8700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.159B $0.011B
F-star Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. F-star Therapeutics Inc., formerly known as Spring Bank Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29